Citius Oncology, Inc.
CTOR
$0.94
$0.011.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.92M | -26.61M | -5.53M | -5.00M | -5.37M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -2.11M | 1.72M | 573.40K | -- | -- |
| Total Other Non-Cash Items | 7.47M | 3.30M | 4.22M | 2.56M | 2.39M |
| Change in Net Operating Assets | 860.00K | 17.76M | -6.61M | -3.06M | 2.98M |
| Cash from Operations | -2.71M | -3.83M | -7.35M | -5.49M | 0.00 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.00M | -600.00K | -4.40M | -5.75M | -- |
| Cash from Investing | -2.00M | -600.00K | -4.40M | -5.75M | -- |
| Total Debt Issued | 9.64M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.73M | -- | 15.13M | 15.17M | -- |
| Repurchase of Common Stock | -- | -61.90K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -723.30K | -169.30K | -- | -- | -- |
| Cash from Financing | 18.64M | -231.20K | 15.13M | 15.17M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.93M | -4.66M | 3.37M | 3.92M | -- |